Glaukos Corp. (GKOS)
167.25
-3.13
(-1.84%)
USD |
NYSE |
Sep 11, 16:00
167.36
+0.11
(+0.07%)
After-Hours: 20:00
Glaukos Enterprise Value : 9.661B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 9.661B |
| September 10, 2026 | 9.845B |
| September 09, 2026 | 10.40B |
| September 08, 2026 | 10.71B |
| September 04, 2026 | 10.26B |
| September 03, 2026 | 10.43B |
| September 02, 2026 | 10.38B |
| September 01, 2026 | 10.22B |
| August 31, 2026 | 10.39B |
| August 28, 2026 | 10.40B |
| August 27, 2026 | 10.52B |
| August 26, 2026 | 10.44B |
| August 25, 2026 | 10.49B |
| August 24, 2026 | 10.74B |
| August 21, 2026 | 10.70B |
| August 20, 2026 | 10.70B |
| August 19, 2026 | 10.97B |
| August 18, 2026 | 10.66B |
| August 17, 2026 | 10.74B |
| August 14, 2026 | 10.68B |
| August 13, 2026 | 10.97B |
| August 12, 2026 | 10.80B |
| August 11, 2026 | 10.53B |
| August 10, 2026 | 10.49B |
| August 07, 2026 | 10.41B |
| Date | Value |
|---|---|
| August 06, 2026 | 9.881B |
| August 05, 2026 | 9.877B |
| August 04, 2026 | 9.854B |
| August 03, 2026 | 9.874B |
| July 31, 2026 | 9.629B |
| July 30, 2026 | 9.735B |
| July 29, 2026 | 9.332B |
| July 28, 2026 | 8.724B |
| July 27, 2026 | 8.758B |
| July 24, 2026 | 8.856B |
| July 23, 2026 | 8.771B |
| July 22, 2026 | 8.814B |
| July 21, 2026 | 8.827B |
| July 20, 2026 | 8.967B |
| July 17, 2026 | 9.047B |
| July 16, 2026 | 8.963B |
| July 15, 2026 | 9.048B |
| July 14, 2026 | 8.790B |
| July 13, 2026 | 8.805B |
| July 10, 2026 | 8.805B |
| July 09, 2026 | 8.944B |
| July 08, 2026 | 8.820B |
| July 07, 2026 | 8.684B |
| July 06, 2026 | 8.569B |
| July 02, 2026 | 8.548B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 204.07B |
| Alphatec Holdings, Inc. | 2.124B |
| Artivion, Inc. | 1.552B |
| ICU Medical, Inc. | 4.902B |
| Insulet Corp. | 9.565B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.38M |
| Revenue (Quarterly) | 185.61M |
| Total Expenses (Quarterly) | 203.99M |
| EPS Diluted (Quarterly) | -0.3124 |
| Gross Profit Margin (Quarterly) | 81.67% |
| Profit Margin (Quarterly) | -9.90% |
| Earnings Yield | -1.95% |
| Normalized Earnings Yield | -1.117 |